日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A case of appendiceal neuroendocrine tumor with metastatic spread in a young patient

一例年轻患者阑尾神经内分泌肿瘤转移病例报告

Hasan, Fariha; Davoodi, Amir; Bordogna, Amy; Dalwadi, Shrey; Timsaal, Yumna; Singh, Avneet; Garcia, Alexander; HooKim, Kim; Roy, Satyajeet

An Unusual Presentation of Cutaneous Bullous Lupus

皮肤大疱性狼疮的一种罕见表现

Buchner, Sara H; Malta, Kiana; Wang, Shiyu; Guevara, Adriana; Glickman, Cynthia; Hookim, Kim; Traisak, Pamela; Karpoff, Marissa; Feinstein, David; Eid, Hala

Kaposi sarcoma in an individual recently diagnosed with HIV

一名近期确诊感染艾滋病毒的患者罹患卡波西肉瘤。

Cronin, Keri Morgan; Desai, Akshay; Hookim, Kim; Contino, Gabriela

Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma

针对 SOX10 缺陷细胞来减少黑色素瘤中的休眠-侵袭性表型状态

Claudia Capparelli, Timothy J Purwin, McKenna Glasheen, Signe Caksa, Manoela Tiago, Nicole Wilski, Danielle Pomante, Sheera Rosenbaum, Mai Q Nguyen, Weijia Cai, Janusz Franco-Barraza, Richard Zheng, Gaurav Kumar, Inna Chervoneva, Ayako Shimada, Vito W Rebecca, Adam E Snook, Kim Hookim, Xiaowei Xu, E

CADM1 is a TWIST1-regulated suppressor of invasion and survival

CADM1 是受 TWIST1 调控的侵袭和存活抑制因子。

Edward J Hartsough ,Michele B Weiss ,Shea A Heilman ,Timothy J Purwin ,Curtis H Kugel 3rd ,Sheera R Rosenbaum ,Dan A Erkes ,Manoela Tiago ,Kim HooKim ,Inna Chervoneva ,Andrew E Aplin

Spatial distribution of biopsy cores and the detection of intra-lesion pathologic heterogeneity

活检组织芯的空间分布及病灶内病理异质性的检测

Calio, Brian P; Deshmukh, Sandeep; Mitchell, Donald; Roth, Christopher G; Calvaresi, Anne E; Hookim, Kim; McCue, Peter; Trabulsi, Edouard J; Lallas, Costas D

Bile duct involvement by hepatocellular carcinoma: A rare occurrence and poor prognostic indicator in bile duct brushing samples

肝细胞癌累及胆管:胆管刷检标本中罕见且预后不良的指标

Bhattarai, Shristi; Graham, Rondell P; Sigel, Carlie S; Shi, Jiaqi; Gonzalez, Raul S; Xue, Yue; Krasinskas, Alyssa M; HooKim, Kim; Adsay, Volkan; Reid, Michelle D

In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms

体内 E2F 报告揭示 MEK1/2-CDK4/6 靶向的有效时间表和 mTOR-S6 耐药机制

Jessica L F Teh, Phil F Cheng, Timothy J Purwin, Neda Nikbakht, Prem Patel, Inna Chervoneva, Adam Ertel, Paolo M Fortina, Ines Kleiber, Kim HooKim, Michael A Davies, Lawrence N Kwong, Mitch P Levesque, Reinhard Dummer, Andrew E Aplin